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ABSTRACT Sup35NM, the prion determining domain of the protein responsible for the yeast prion phenomenon [C], has
become a powerful model for studying key processes in amyloid-related human diseases. One of these processes is
a conformational conversion of soluble precursor protein into insoluble ﬁbrillar structures. In this study, we created a set of
Sup35NM mutants and used proteolytic digestion coupled with mass spectroscopy to monitor local structure of the protein
during polymerization. Experimental data were compared to a network model and showed that during the conformational
conversion residue Arg-28 became highly protected from cleavage, residue Arg-98 remained partially solvent exposed, and
residues between 28 and 98 showed an intermediate degree of protection. In addition, we found that a distinct subset of
proteolytic polypeptides spanning 28–98 residues segment spontaneously formed stable dimers. This ﬁnding suggests that the
[29–98] region is the key interacting region of Sup35NM responsible for amyloid conversion.
INTRODUCTION
A range of human diseases that includes systemic amyloid-
osis, neurodegenerative diseases, and transmissible spongi-
form encephalopathies is accompanied by accumulation of
highly ordered proteinaceous aggregates commonly called
amyloids (1–5). The dominant component of these aggre-
gates is a protein or a protein fragment that normally exists in
a soluble, often well-folded globular conformation (6–8).
The spectrum of proteins capable of forming amyloids is
ever increasing, leading to a suggestion that amyloid is an
alternative misfolded state accessible for all proteins. This
misfolded state is characterized by exceptionally high
stability indicating that it populates signiﬁcantly lower
energy levels than its soluble counterpart. A distinct feature
of the amyloids is that their structure consists of bundles of
ﬁbers made of protein molecules stabilized by a large
number of hydrogen bonds (9–11). Although the structure of
the soluble precursor protein could be arbitrary, the amyloid
core formed by majority of proteins attains similar cross-b
structures as evaluated by x-ray diffraction (9,12). This
structural homomorphism between soluble precursor pro-
teins and amyloid suggests that there may be a common
mechanism governing the transition of a protein from its
normal, usually soluble state into the amyloid assembly.
Understanding the details of the amyloid transition may fuel
the discovery of pharmacological compounds that would
block and reverse the formation of amyloids. Such com-
pounds could provide a therapy for the currently incurable,
debilitating diseases associated with amyloids. Insight into
amyloid transition also provides rational principles for the
creation of new biologically inspired, protein-based nano-
materials and devices (13,14).
Sup35NM is an N-terminal fragment of prion protein
Sup35p from Saccharomyces cerevisiae. It represents the
intrinsically unstructured portion of otherwise well-folded
cytosolic protein involved in translation termination activity
(15). Secondary structure prediction algorithms applied to
this fragment show the absence of a-helices and negligible
b-sheet content that agree well with circular dichroism spec-
tra for a freshly reconstituted puriﬁed fragment at phys-
iological conditions (16). However, the lack of secondary
structure does not necessarily mean that the protein is
folded randomly because it was shown that natively un-
folded proteins while lacking secondary structure may have
residual structure (17–19).
The unfolded proteins have a number of properties placing
them in a class distinct from the globular proteins, including
exceptionally large hydrodynamic radii (20), high structural
plasticity, and the ability of acquiring a fold upon binding to
a cognate partner (21). High structural plasticity of natively
unfolded proteins makes it easy for them to sample the
conformational space, and because they cannot fold into stable
globular conformation, they have a greater chance ‘‘to ﬁnd’’
the amyloid state during their lifetime (21). Sup35NM is not
an exception. It spontaneously forms homogeneous (as judged
by electron microscopy (EM)) amyloid ﬁbers under physio-
logical conditions, thereby providing a model system for
studying the general mechanism of amyloid conversion (22).
The conversion of soluble Sup35NM into amyloid initiates
spontaneously and resembles a nucleated polymerization
reaction characterized by a measurable lag phase followed by
rapid cooperative transition. When a fraction of preformed
ﬁbers is added to the soluble protein, the initial rate of reaction
becomes a linear function of both the number of ﬁber ends and
the concentration of soluble protein (23). Although a phenom-
enological model of this polymerization process has been
developed (23), little is known about the structural transitions
that accompany this conversion. The primary reason for the
scarcity of structural information about amyloids is their
physicochemical properties. For example, condensing poly-
peptides cause severe line broadening that precludes residue
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assignments in solution NMR. Additionally, because ﬁbrils
possess only one translational symmetry, x-ray crystallogra-
phy cannot be applied because it requires that the sample has
three-dimensional translational symmetry. Recent advances in
solid-state NMR enable resolution of the ﬁnal structural state
of the ﬁbrils (24–27). However, there are no high-resolution
methods (1–10 A˚) for the detection of conformational changes
and transitional states during the conversion process. This
leaves an open door for the application of the less efﬁcient
low-resolution methods (10–50 A˚) including mass and optical
spectroscopy (28–30), EPR (31,39), and reconstructive
electron microscopy (32,33).
Methods to probe the structure and changes in the
structure based on the proteolytic digestions coupled to
mass spectroscopy were used in the past. The most recent
and relevant to our work are studies of the structure of SH3
(34) and Ure2p (35) ﬁbrils. Proteolytic mapping is based on
the relative susceptibility of disordered and randomly folded
regions of the protein to proteolytic cleavage, compared with
the resistance of the regions that are tightly folded (36). A
typical experiment involves a limited digestion with either
a speciﬁc or nonspeciﬁc protease, followed by detection of
the digestion products by mass spectrometry. The traditional
methods of analysis employed in proteolytic mapping have
two shortcomings. First, proteolytic peptides are not related
quantitatively to their precursors. This makes it impossible to
compare or to calculate the cleavage rates at different sites. In
addition, the traditional methods assume that the release of
proteolytic peptides in solution does not depend on the stage
of amyloid formation. In reality, peptides located in the
amyloidogenic regions could be dramatically less soluble if
cleaved from the ﬁber than from the soluble protein.
We have developed a dynamic network model of
proteolytic digestion to overcome the limitations of current
methodology. Our model allows measuring the aggregation
rates of proteolytic peptides and their changes, whereas this
information is lost in the traditional approach. Additionally,
it uses conservation laws existing between the proteolytic
fragments to alleviate the experimental errors. These features
of the model increase the robustness of information derived
from the digests and allows the deduction of the degree of
conformational protection occurring at chosen neighbor-
hoods of the protein’s local structure. We have used this
model to interpret proteolytic digestion data and elucidate the
structural changes occurring during the conformational
conversion of Sup35NM from its soluble to amyloid state.
Digestion model
The time course of a protein digestion was modeled using
a graph, where nodes represent all possible fragments
produced by speciﬁc protease cleavage joined by directed
edges representing cleavage pathways. Fig. 1 shows
a network model of the cleavage process for a peptide with
two cleavage sites. This model places an explicit link
between the observed cleavage product (the node’s relative
intensity) and the surface exposure of all residues that have
to be cleaved to make that product (the subset of cleavage
rates). The dynamics of this graph are described by a set of
differential equations. In the initial stages of limited
digestion, when enzyme concentration is signiﬁcantly lower
than the substrate concentration, the cleavage rates could be
taken constant. Additionally, if we assume proteolytic
peptide aggregation rates during the same period to be
constant as well, then the model becomes a linear system with
constant coefﬁcients and can be solved algebraically. The
number of nodes (differential equations) depends quadrati-
cally on the total number of cleavage sites. Because Sup35NM
has two arginines, cleaving it with Arg-C protease yields ﬁve
fragments. Therefore, the cleavage dynamics are described by
the following system of differential equations (Eq. 1):
dx14
dt
¼ ðs11 s21 d14Þx14
dx13
dt
¼ s2x14  ðs11 d13Þx13
dx24
dt
¼ s1x14  ðs21 d24Þx24
dx12
dt
¼ s1ðx141 x13Þ  d12x12
dx23
dt
¼ s1x131 s2x24  d23x23
FIGURE 1 Digestion network model. Figure shows schematics of
proteolytic digestion for a protein with two cleavage sites. Proteolysis of
wild-type Sup35NM by Arg-C protease is described by this model.
Rectangles represent different proteolytic peptides liberated during the
digestion. Bended arrows represent the graph’s edges. They signify cleavage
pathways. Large light gray circles represent nodes of the graph. The
intensities of the nodes correspond to the time-dependent normalized
intensities of the proteolytic fragments Xij. They are calculated as a solution
to Eq. 1. The solution depends on S1 and S2—cleavage rates at proteolytic
sites 1 and 2. The cleavage rates are determined by minimizing Eq. 2.
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dx34
dt
¼ s2ðx141 x24Þ  d34x34; (1)
where xij is concentration of a fragment ij, s1, s2 are cleavage
rates at Arg-28 and Arg-98, and dij are the intrinsic decay
(aggregation) rates. Each structural state of the protein is
described by the set of coefﬁcients s1, s2, and dij. Cleavage
rates relate to the protein’s topology whereas decay rates
signify the peptide’s propensity to aggregate. Fitting s1, s2,
and dij to satisfy the observed data provides a structural
snapshot of the protein. This is accomplished by a traditional
least-squares method. Let f Ci ¼ f Ci ðs1; s2; dij; tÞ be solutions
of Eq. 1, f Ei ðtÞ concentrations of observed fragments, and wi
statistical weights.




i ðtÞ  f Ci ðs1; s2; dij; tÞ
 2
: (2)
Then minimization of C provides s1, s2, and dij cor-
responding to the duration of digestion time t, which is set
to be constant for all samples in a set.
If the number of experimentally observed f Ei is equal to or
less than the total number of ﬁtting parameters (dij and si), it
becomes necessary to reduce the number of independent
parameters. One possibility is to determine cleavage and
decay rates in separate experiments. The ﬁrst experiment is
designed in a way that minimizes the aggregation effect by
employing a disaggregating step before analysis. Then, the
second experiment is designed to speciﬁcally determine
the decay rates by performing peptides recovery from the
digestion mixture under physiological conditions.
The number of independent solutions to Eq. 1 under
certain conditions could be less than the number of equa-
tions. In aggregation-free experiments, we have a number
of conservation laws relating the peptide concentrations. For
example, concentration of fragment x12 in Sup35NM diges-
tion is equal to the sum of x23 and x24. Similar relation also
exists for x34. These conservation laws are easily generalized









Equation 3 and other relations of that kind that exist
between proteolytic fragments are instrumental for the
detection and correction of systematic experimental errors.
Such corrections enhance the robustness of data ﬁts.
EXPERIMENTAL METHODS
Mutagenesis
Wild-type Sup35NM cDNA was subcloned into pET-22 vector (Novagen,
Madison, WI) in tandem with C-terminal hexahistidine tag. Point mutations
were introduced using QuikChange II site-directed mutagenesis kit
(Stratagene, La Jolla, CA). The ﬁdelity of all constructs was veriﬁed by
sequencing.
Protein puriﬁcation
Proteins were expressed in Escherichia coli and puriﬁed via metal chelation
and reverse phase chromatography. Details are provided in Supplementary
Material.
Preparation of ﬁber reactions
Proteins were rehydrated in 25 mM MES pH 4.5 and spin ﬁltered through
100 KDa cutoff membrane (OMEGA100K, Pall, Port Washington, NY).
Unseeded ﬁbers were formed at 12.5 mM concentration in PBS in gently
stirred reactions. Seeded reactions were initiated by addition of 5% (w/w)
preformed seed. The seeded reactions were frozen on dry ice at indicated
time (typically 1, 10, 30, 60 min after addition of seed).
Proteolytic digestions
In general, enzyme manufacturer’s recommendations were followed. Arg-C
enzyme [E.C. 3.4.22.8] was purchased from Roche. Digestion time was set
at 20 min. To stop the digestions at desired time points, double volume of
6 M GdmCl was added and samples were desalted.
Desalting
POROS R2 reverse-phase resin was added to the samples and mixed on
a vortex at 30C for 30 min. Next, resin with bound peptides was separated
by spin ﬁltration in a 0.45 mMNANOSEP MF GP device (Pall) and washed
three times with 0.1% TFA in water. Peptides were eluted with 50% MeOH
0.1% TFA.
Mass spectrometry
Mass spectrometry was performed on Applied BioSystems Voyager-DE
STR MALDI-TOF. Sinapinic acid was used as crystallization matrix. Mass/
charge values for proteolytic fragments were calculated using ProteinPro-
spector (University of California, San Francisco). Spectra were analyzed by
M/Z software (ProteoMetrics, New York, NY).
Normalizing the MALDI mass spectra
The raw intensity of each fragment Iij was calculated by adding intensity of
the singly charged species i11ij plus 1/2 of intensity of the doubly charged
species i21ij plus double intensity of the corresponding homodimer d
homo
ij plus
intensity of the corresponding heterodimer dheteroij . The normalized intensity
of a fragment xij was obtained by multiplying raw intensity Iij by 100% and
dividing it by the combined raw intensities of all fragments present in the
spectrum.





1 2dhomoij 1 d
hetero
ij
xij ¼ 100% Iij+Iij:
Thioﬂavin-T binding
TfT binding was performed as previously described (23). Details are
provided in Supplementary Material.
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Electron microscopy
Seeded ﬁbril samples were negatively stained with uranyl acetate and
imaged on JEOL JEM-2200FS microscope.
Data ﬁts
All calculations and data ﬁts were performed using CAS Mathematica
(Wolfram, Champaign, IL).
RESULTS
Arg-28 and Arg-98 gain protection during
polymerization at different rates
The main aim of this study was to elucidate the conforma-
tional changes occurring at the N-terminal region of
Sup35NM during the ﬁber assembly. Although the proposed
model accounts for peptide aggregation, we left the ex-
perimental determination of the aggregation rates outside of
the scope of this study, and performed the experiments under
conditions that minimize the effects of aggregation. We
prepared a set of ﬁve samples representing ﬁve time points
of the polymerization reaction by freezing aliquots of seeded
ﬁber formation reaction on dry ice. The ﬁrst sample had no
seed and thus represented the soluble, intrinsically un-
structured state. The second sample was withdrawn 1 min
after addition of the seed and had ;5–10% of ﬁbrous
material. The third and fourth samples had;50% and;75%
of polymerized protein. The last sample was taken two hours
after addition of seed and contained .90% ﬁbrous material.
Evaluation of the ratio between soluble and ﬁbrous material
was made by TfT binding (Fig. 4 B). Upon completion of the
reaction, the samples were simultaneously thawed out,
digested with a protease that hydrolyzes peptide bond on
the C-terminal side of arginine residue (Arg-C protease) and
disaggregated with GdmHCl.
Digestion of Sup35NM with Arg-C protease produces up
to ﬁve proteolytic fragments, because wild-type Sup35NM
has two arginines. Visual examination of mass spectra in
Fig. 2 shows that relative fragment intensities are changing
dramatically between the samples collected at initial and
terminal stages of ﬁber formation. In the initial, unseeded
sample, the [29–98] fragment is the most intense (Fig. 2 A).
This fragment is produced when Sup35NM is cleaved at
both sites, Arg-28 and Arg-98. The second highest peak is
the [2–98] fragment that contains one missed cleavage at
Arg-28. The observed digestion pattern suggests that both
cleavage sites are accessible (although to different degrees)
on a soluble protein before the ‘‘seed’’ is added to initiate
ﬁber formation. The sample taken immediately after
addition of the ‘‘seed’’ shows that the peak corresponding
to [29–98] drops in intensity and becomes nearly equal to
the [2–98] fragment (Fig. 2 B). This result is only possible
if the cleavage rate at the Arg-28 site decreases. The next
samples in sequence show that the [29–98] peak pro-
gressively declines whereas the [2–98] remains the highest
(base) peak of the spectrum (Fig. 2, C and D). Two hours
after addition of the seed, the [29–98] loses 87% of its
intensity (Fig. 2 E).
Arg-28 gains protection faster than Arg-98, but
remains partially exposed in ﬁber
To conﬁrm visual observations and to put them into the
semiquantitative perspective, we ﬁtted the digestion model
to the experimental data. The values of cleavage rates
obtained in these ﬁts are strictly semiquantitative, and could
only be used to illustrate the changes in cleavage rate ratios
between samples at different time points. The results are
summarized in Table 1. ‘‘No seed’’ sample gives ;3.1 av-
erage ratio between Arg-28 and Arg-98 rates, that grows
rapidly to over 18 for the ‘‘120-min’’ sample. This tells us
that Arg-28, while it is partially exposed in soluble protein,
becomes rapidly sequestered inside of the protein during the
ﬁber assembly. Arg-28 is buried signiﬁcantly, if not com-
pletely inside the ﬁber core, because intensity of the [2–28]
fragment quickly reduces to zero and intensity of the [29–98]
FIGURE 2 Sup35NM Arg-C digestion spectra. MALDI spectra of
Sup35NM digested with Arg-C protease. The ﬁber formation reactions
were initiated by addition of seed and then frozen at various stages of
polymerization. (A) No seed added; (B) 1 min after addition of seed; (C) 30
min; (D) 60 min; (E) 120 min. All samples were digested simultaneously,
desalted and analyzed by MALDI.
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fragment reduces from 65 to 8%. In addition, the ﬁtted model
conﬁrms that Arg-98 becomes progressively less exposed to
the solvent during ﬁber formation, because the value of the
rate declines during the conversion process. However, a
signiﬁcant portion of Arg-98 remains at the surface of the
ﬁber core, as judged by the presence of the [2–98] fragment
in the ﬁbrous sample. This indicates that Arg-98 could be in
at least two topologically nonequivalent positions with
respect to the ﬁber surface.
Insertion of additional arginines expands the
method’s coverage
Initial success in detecting the conformational changes in
Sup35NM using Arg-C encouraged us to further experiment
by making a set of arginine mutants. We decided to use
arginine point mutations as engineered cleavage sites to
probe the conformational changes at chosen points of protein
fold. Therefore, we created six mutants of Sup35NM: G7R,
N21R, G51R, G58R, G68R, and G96R; we expressed them
in E. coli, puriﬁed, and veriﬁed identities of the resulting
proteins by LC-MS. We collectively refer to that set as
Sup35RM mutants.
RM behave similarly to NM
Because all of the mutants lead to the placement of a charged
residue in the region sensitive to the charge mutations (37),
we tested whether these mutations abolish the ﬁber
formation, or alter the ﬁber formation properties. First, we
formed ﬁbrils by dissolving lyophilized proteins in phos-
phate-buffered saline and examined them by electron
microscopy. EM images (Fig. 3) show that all mutants share
morphology similar to the wild-type Sup35NM ﬁbrils,
characterized by uniform nonbranched ﬁlaments of 10–30-
nm diameter up to several micrometers long (22).
Next, we examined kinetics of unseeded and seeded ﬁber
formation (Fig. 4) using Thioﬂavin-T binding as an indicator
of amyloid conversion (23). In unseeded reactions, all except
G7R mutants showed kinetics (chieﬂy characterized by the
duration of lag phase) comparable to the wild-type
Sup35NM (Fig. 4 A). G7R had a lag phase 45% longer
than the rest. In seeded reactions, all but N21R had assembly
kinetics similar to wild type (Fig. 4 B). N21R had ;50%
decrease in apparent rates of assembly. Thus, we concluded
that seeded ﬁbers formed by ﬁve out of six arginine mutants
in vitro were comparable to wild type and thus could provide
the structural information that is possible to integrate with
that of wild-type NM.
Protection gain is faster for sites closer
to N-terminus
The set of six Sup35RM mutants was subjected to the same
Arg-C/MS analysis as wild type described above. Fig. 5
shows the MALDI spectra for the digests of the initial and
the ﬁnal ﬁber formation samples. The ﬁgure shows that the
distribution of intensities changes signiﬁcantly between
initial and terminal samples for all but N21R proteins. Table
2 summarizes the results of data ﬁts. With the notable
exceptions of N21R and G96R, cleavage rates at Arg-28 and
Arg-98 sites of Sup35RM mutants followed the course
similar to the wild type. First, Arg-28 was gaining protection
faster than Arg-98. Second, all cleavage sites gained some
protection during the ﬁber formation. The gain in protection
was highest for the sites close to the N-terminus. In
particular, Arg-7, Arg-21, and Arg-28 gained protection
faster than the other sites, and Arg-21 appears to be protected
more than Arg-28 at all stages of polymerization. Cleavages






NS§ 0.0555 0.1697 3.1 4.9
1 0.0338 0.1589 4.7 3.6
30 0.0219 0.1258 5.8 5.5
60 0.0159 0.1395 8.8 5.7
120 0.0054 0.1001 18.6 2.1
*Cleavage rate at Arg-28.
yCleavage rate at Arg-98.
zResidual sum of squares.
§No-seed sample.
FIGURE 3 Sup35RMEM images. Electron micrographs of the negatively
stained seeded ﬁber samples: Sup35NM-G7R, Sup35NM-N21R,
Sup35NM-G51R, Sup35NM-G58R, Sup35NM-G68R, and Sup35NM-
G96R. All proteins assemble into ﬁbers with similar morphology. Scale
bar, 100 nm.
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at Arg-58 and Arg-68 were moderately frequent throughout
all stages of polymerization, and gained less protection than
N-terminal sites, indicating that these sites could be in
several topologically nonequivalent positions in respect to
the ﬁber surface, similarly to Arg-98 (see Sup35NM
digestion results). G96R was different from the rest. A
concern about ﬁdelity of G96R data ﬁts forced us to rely on
visual interpretation of the digestion. Thus, we provide here
only the visual interpretation of the digest (Fig. 5). At the
initial stage the [29–96] fragment is the most intense, [2–96]
is second, [29–98] is third, and [2–28] is present. This tells us
that initially all three sites are exposed, although to different
degrees. Arg-98 appears to be twice less exposed than Arg-
96, and Arg-28 is the least exposed. Two hours later [2–28]
and [28–98] disappear, [2–96] becomes the dominant peak,
[29–96] loses about half of its intensity. This shows that Arg-
28 becomes sequestered inside of the ﬁber core, whereas
Arg-96 and Arg-98 remain partially exposed. Because
peak ratios of [29–96]:[29–98] in the ‘‘no-seed’’ sample and
[2–96]:[2–98] in ‘‘120-min’’ samples are;2:1, it is possible
FIGURE 4 Sup35RM thioﬂavin-T kinetics. (A) Unseeded kinetics.
Soluble protein samples were mixed with TfT and gently stirred during
the course of reaction. The changes in TfT ﬂuorescence occurs when TfT
binds to the ﬁbers. All proteins except Sup35NM-G7R show unseeded
kinetics similar to the wild-type Sup35NM. Sup35NM-G7R has lag phase
;40% larger than wild type. (B) Seeded kinetics. Seeded polymerization
reactions were monitored by TfT binding. All proteins except Sup35NM-
N21R show kinetics similar to wild-type Sup35NM. N21R mutant has
slower apparent assembly rates than the wild type.
FIGURE 5 Sup35RM digestion spectra MALDI spectra of initial no seed
(left) and ﬁbrous (right) samples digested with Arg-C protease. Relative
intensities of the fragments change signiﬁcantly during the course of ﬁber
formation. Spectra of initial samples is dominated by completely cut end-
fragments, whereas ‘‘120 min’’ ﬁber samples show signiﬁcant presence of
undigested fragments containing one or two cleavage sites.
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that cleavage rates at Arg-96 is about twice that of Arg-98
site, and is constant during ﬁber formation.
Proteolytic peptides form highly stable dimers
Initial examination of the MALDI spectra showed the
presence of peptides with masses that differed from the
masses of the expected proteolytic fragments and their
multiple charged states. Further analysis showed that these
peaks correspond to the homo- and heterodimers formed by
the proteolytic peptides liberated during the Arg-C cleavage
(Fig. 6). The detection of the peptide dimers in the physical
vacuum of the mass spectrometer is perplexing; and because
our mass spectrometer had insufﬁcient resolution we cannot
say at this point if they are stabilized by noncovalent
interactions or are joined covalently. Nevertheless, the fact
that only selected peptides formed dimers indicate that there
must be speciﬁc interaction between them.
Table 3 summarizes the dimers observed during the
cleavage of Sup35RM with Arg-C. The most ubiquitous
homodimers are formed by the [2–98] and [29–98] peptides.
In the case of G96R these are replaced by [2–96] and
[28–96], apparently because the cleavage at Arg-96 is more
efﬁcient than at Arg-98. Homodimers are typically formed at
initial stages of polymerization, when the cleavage at Arg-28
is still frequent. At later stages, abundance of the [29–98]
fragment drops and heterodimers become more prevalent.
The heterodimers are typically formed by the [2–98] and
[29–98] peptides. In addition, [8–98], [22–98], [52–98], [58–
98], [2–68], and [29–68] participate in the dimerization. The
[2–28], [2–51], [29–51], [29–58], [69–98], [69–275], [97–
275], and [99–275] fragments apparently do not participate
in the dimerization, because all homodimers or heterodimers
were formed without their participation.
Superimposing the sequences of the interacting peptides
and subtracting the sequences of the noninteracting peptides
reveals the region of Sup35NM that is most likely to be
involved in the formation of ﬁber core (Fig. 7). The broad
segment [29–98] certainly encompasses the entire ﬁber-
forming region. But the narrower fragment [29–68] probably
encompasses the most strongly interacting part of the ﬁber
core, because all dimerizing peptides either contain this
region or share at least a 10-amino-acid-long stretch of it.
Notably, [29–68] is the shortest of all dimerizing peptides.
DISCUSSION
What are the conformational changes that Sup35p
purportedly self-perpetuate?
At the heart of [C] prion phenomena lies the propagation of
self-perpetuating conformational changes in Sup35p protein
(38). Although Sup35p is actively studied in several
laboratories around the world and more than two dozen
articles were published about it in the last eight years, no
systematic study of the Sup35p conformational changes on
TABLE 2 Fitted model of Sup35RM/Arg-C digestion





(min1) S3/S1 S3/S2 J
2§
G7R 1 min 0.0200 0.0365 0.1907 9.5 5.2 1.9
30 min 0.0046 0.0137 0.1799 39.3 13.1 8.9
60 min 0.0049 0.0128 0.1348 27.8 10.6 10.6
120min 0.0010 0.0031 0.1316 135.7 42.4 9.2
N21R NS{ 0.0721 0.0580 0.1724 2.4 3.0 5.8
1 min 0.0760 0.0721 0.1905 2.5 2.6 4.2
30 min 0.0233 0.0675 0.1299 5.6 1.9 39.8
60 min 0.0217 0.0673 0.1401 6.5 2.1 32.9
G51R NS{ 0.1412 0.0258 0.1797 1.3 7.0 4.5
1 min 0.0248 0.0205 0.1742 7.0 8.5 2.1
30 min 0.0126 0.0114 0.1473 11.7 12.9 12.9
60 min 0.0060 0.0121 0.2166 36.2 17.9 2.1
120min 0.0038 0.0084 0.1728 45.7 20.6 0.8
G58R NS{ 0.0467 0.0500 0.1038 2.2 2.1 96.9
1 min 0.0219 0.0263 0.0631 2.9 2.4 31.3
30 min 0.0189 0.0209 0.0499 2.6 2.4 26.6
60 min 0.0138 0.0292 0.0825 6.0 2.8 38.1
120min 0.0107 0.0138 0.0752 7.0 5.4 52.4
G68R NS{ 0.0815 0.0111 0.0299 0.4 2.7 821.1
1 min 0.0161 0.0079 0.0428 2.7 5.4 556.9
30 min 0.0046 0.0102 0.0464 10.0 4.5 286.8
60 min 0.0044 0.0107 0.0525 12.0 4.9 206.0
120min 0.0034 0.0123 0.0521 15.5 4.2 173.2
*yzCleavage rates at ﬁrst, second, and third cleavage sites counted from the N-terminus.
§Residual sum of squares.
{No-seed sample.
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a molecular level were ever published. The ﬁrst structural
study of Sup35NM ﬁbers on the molecular level came in
2004 (39). It shows mobility proﬁles of paramagnetic probes
attached at different positions along the Sup35 sequence
detected by EPR. The study showed that the minimum
mobility in the ﬁber segment [26–116] corresponds to the
[36–76] region. That study determined our choice of residues
for the conformational experiments. Before using Arg-C
protease we experimented with trypsin, chymotrypsin,
proteinase-K and Asp-N. The pilot study showed that indeed
the [141–253] part of Sup35 is highly ﬂexible, although not
totally random at both soluble and ﬁbrous states, while
N-terminus undergoes some ‘‘protection’’ from cleavage
(V. A. Goncharov, unpublished data). The deviation of the
cleavage pattern from randomness (characterized as equal
cleavage at all sites) for the monomeric state of Sup35NM
shows that it has some residual structure.
The advantages of a networking model
The method used in this study relies on the detection of
changes in degree of protection from cleavage as a manifes-
tation of conformational changes in the protein’s structure.
The novelty of our approach lies in the usage of a network
model that integrates the pieces of proteolytic data into one
system. It improves reliability and allows probing the
structural changes of the amyloid ﬁbers and other protein
complexes that are difﬁcult to study.
Structural transitions in Sup35NM
Initially, soluble Sup35NM is predominantly monomeric (23).
Sup35NM at this stage is in an extended structural state. This
state is not a random coil, but probably a collection of small
(3–7 amino acids) segments with stable intraresidue contacts
joined by segments of random coil. Threefold differences in
cleavage rates at Arg-28 and Arg-98 show that Arg-28 is
partially protected in one such small folding element. Partial
protection at Arg-7, as well as nonrandom pattern of
chymotrypsin digest (data not shown) also supports this
view. The very N-terminus of Sup35NM [2–12] could be
involved in nucleation, because G7R is the only mutant that
had shown ;45% extension of the lag phase in unseeded
reaction (Fig. 4 A). However, it is unlikely to participate in
assembly, because: a), this mutant had similar rates of
assembly to the wild type; and b), Arg-C was cleaving at Arg-7
position even in the ﬁbrous state. Another abnormal mutant
was also found at the N-terminus. N21R had slower apparent
assembly rate in seeded reaction, indicating that the charged
residue at this position is interfering with assembly process.
Addition of the ‘‘seed’’ had a strong depressing effect on the
accessibility of N-terminal residues, Arg-28 in particular.
Immediately after addition, the cleavage rate at Arg-28
dropped, while little ﬁbrous material was produced at this
stage. These results suggest that presence of ﬁbrous template
was somehow ‘‘communicated’’ to the rest of the protein
molecules, triggering the beginning of conformational
changes. The ‘‘communication’’ effect could explain the
less-than-linear dependence of assembly rates on the protein
concentration at high monomer concentrations. Polymeriza-
tion that follows addition of the seed leads to the gain in
protection from cleavage for the most of the mutations.
Interacting region
The proliferation of the dimers formed from proteolytic
peptides points to the strong interaction that exists in the
[29–68] segment of the Sup35NM. This ﬁnding is in
agreement with previous work that showed that minimum
mobility of side chain linked paramagnetic probes corre-
spond to roughly the same region in the ﬁbrous structure
(39). If the [29–68] fragment alone can form amyloid ﬁbers
comparable to Sup35NM, it could greatly simplify the ﬁber
FIGURE 6 Sup35 peptide dimers MALDI spectra show the presence of
stable dimers formed from the proteolytic peptides. Dimers are formed only
if both peptides span the residue subset from [29–98]. Thus, homodimers
[2–98]2, [29–98]2 and heterodimers [29–98] 3 [2–98] are formed, but not
[2–28] 3 [2–98] or [2–28]2.
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polymerization model and make it tractable for molecular
dynamics simulations as well as more amendable for
biochemical studies.
The ensemble averaging problem
We are fully aware of one fundamental problem that is
inherent in all low-dimension, low-resolution methods in-
cluding ﬂuorescence, mass, or Fourier transform infrared
spectroscopy. That is the uncontrolled averaging over mul-
tiple structural states present at each sampling point. The
detected signal represents all conformations present and could
be interpreted as a state that in fact is never present in the pure
form. The typical example is ‘‘partial’’ solvent accessibility.
If partial number reaches above the error limit of experiment,
let us say ;10–15%, it becomes quite probable that in fact
more than one structural conﬁguration contributes to the
signal. In other words, it is most likely that 10% of these re-
sidues are fully exposed, while the rest are buried, rather than
assuming that the residue is close to the surface and ‘‘pops
out’’ 10% of the time. In case of Sup35NM, Arg-98 is such
a residue. It gains protection during ﬁber assembly, but even
in the mature ﬁber a signiﬁcant portion of Arg-98 is solvent
exposed. We interpret this as Arg-98 being in more than one
topologically nonequivalent position. Additional experi-
ments and enhancements of the technique are necessary to
untangle these structural ensembles. One approach that could
be fruitful is the use of a very low number of molecules per
experiment, ideally just one at a time.
The results of this work present only a tiny piece of
information, a short glimpse at the processes happening
during the Sup35NM ﬁber assembly. The experimental part
of our method is traditional, but we used a novel method of
analysis that looks at proteolytic disintegration as a dynamic
process, and accounts for all parts of the multivariate system.
This ‘‘network’’ approach could offer dramatically more
information about protein structure than the traditional
‘‘piecewise’’ method. This new method should be applicable
to a variety of proteins and protein complexes that are
difﬁcult to study, including other amyloids, glycoproteins,
and membrane proteins.
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